ArticleBlood2015
STAT3: too much may be worse than not enough!
Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Inborn errors of regulatory T-cell differentiation and function.The Journal of allergy and clinical immunology · 2025Review
- NovelImmune network · 2025Article
- Infections in Disorders of Immune Regulation.Pathogens (Basel, Switzerland) · 2024Review
- Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.Frontiers in oncology · 2023Review
- Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations.Journal of clinical immunology · 2022Article
- Precision medicine: The use of tailored therapy in primary immunodeficiencies.Frontiers in immunology · 2022Review
- Defining and targeting patterns of T cell dysfunction in inborn errors of immunity.Frontiers in immunology · 2022Review
- The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance.Frontiers in immunology · 2022Review
- [Immune dysregulation syndrome caused byZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2021Article
- Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.BMC complementary medicine and therapies · 2021Article
- Targeted Therapy with Biologicals and Small Molecules in Primary Immunodeficiencies.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2020Review
- Editorial: Application of Cytometry in Primary Immunodeficiencies.Frontiers in immunology · 2020Article
- Review
- Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation.Frontiers in immunology · 2019Article
- Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside.Frontiers in pediatrics · 2019Review
- STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity.International journal of molecular sciences · 2018Review
- Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.Cancer immunology, immunotherapy : CII · 2017Review
- Targeted strategies directed at the molecular defect: Toward precision medicine for select primary immunodeficiency disorders.The Journal of allergy and clinical immunology · 2017Review
- Signal transducer and activator of transcription 3: a year in review.Current opinion in hematology · 2016Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25614633What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.